Previous studies demonstrated that genetic variation in OGG1 affects cancer susceptibility; the frequency of the OGG1 326Cys allele was found to be significantly higher in patients when compared with controls [22], [24], [25], [37], [38]; however, this association was not replicated by other studies [9], [13]–[17]. This evidence concerns the gene OGG1 and cancer.